Dr Anthony R. Cox

Career history

• 2009 - to date Lecturer in Clinical Therapeutics
  
• 2002-2009 Teaching Fellow (Pharmacy Practice), Aston University
• 2000- to date Senior Pharmacovigilance Pharmacist, West Midlands Centre for Adverse Drug Reaction Reporting
• 1999-01 Senior Pharmacist (Teacher-Practitioner), Sandwell and West Birmingham Hospitals NHS Trust , Birmingham
• 1995-99 Patient Services Pharmacist, Dispensary Manager and Directorate Pharmacist, Dudley Group of Hospitals NHS Trust
• 1993-95 Basic Grade Pharmacist, Birmingham Heartlands NHS Trust
• 1992-93 Pharmacy Manager, Gardiner's Chemists, Burnley
• 1991-92 Pre-registration Pharmacist, Blackburn, Hyndburn and Ribble Valley Health Authority

Research interests

• Adverse drug reactions and pharmacovigilance
• Public perceptions of drug safety and benefits of drugs
• Medical error
• Evidence Based Medicine

Editorial / professional offices

• Member of the editorial board of the Journal of Clinical Pharmacy and Therapeutics
  
• Secretary, Public Relations Officer, and  webmaster of the Birmingham and District Branch of The Royal Pharmaceutical Society of Great Britain.
  
• Honorary auditor of the Royal Pharmaceutical Society of Great Britain 2003-2005.
• Member of the editorial board of The Pharmaceutical Journal, from 2001-2003.
• Series Editor for Pharmacy in Practice 2000-2002 (Case studies of adverse drug reactions).

Recent research and publications

• Cox AR. MMR: a saga of bad science and scare stories that swayed healthcare professionals. The Pharmaceutical Journal 2010:284:157 [link]
  
• Cox AR. Butt TF, Ferner RE. An analysis and comparison of commonly available United Kingdom prescribing resources. Journal of Clinical Pharmacy and Therapeutics Published Online: Feb 8 2010; DOI: 10.1111/j.1365-2710.2009.01125.x
• Cox AR, Anton C, McDowell SE, Marriott JF, Ferner RE. Correlates of spontaneous reporting of adverse drug reactions within primary care: the paradox of low prescribers who are high reporters. Br J Clin Pharmacol 2010. "Accepted Article"; doi: 10.1111/1365-2125.2010.03637.x
• Anton C, Cox AR, Ferner RE. Improving follow-up rates in spontaneous adverse drug reaction reporting: effectiveness of a targeted letter used by a regional centre in the UK. Drug Saf. 2009;32(12):1135-40
• Cox AR. Patient reporting of adverse drug reactions. Pharmacovigilance Review 2009; 3(2):18-21
• Cox A, Layton D. Adverse drug reactions: Neuraminidase inhibitors: widespread use for influenza may reveal more adverse effects. The Pharmaceutical Journal 2009; 282:621-622
• Layton D, Cox A. Antipsychotics and stroke: the story to date. The Pharmaceutical Journal 2009; 282: 30
• Cox A. Involving patients in reporting adverse drug reactions should be welcomed. The Pharmaceutical Journal 2009; 282: 16-17
• Cox AR, Ferner RE. Prescribing errors in diabetes. The British Journal of Diabetes and Vascular Disease 2009;9(2):84-88
• Cox AR, McDowell S. A response to the article on the association between paracetamol/acetaminophen: use and Autism by Stephen T. Schultz. Autism 2009;13:123-124
  
• Cox A, Layton D. Adverse drug reactions: Neuropsychiatric drug reactions associated with varenicline (Champix). The Pharmaceutical Journal 2008;281:129 [link -registration required]
• Cox AR. Assessing, managing and reporting adverse drug reactions may better equip us to minimise medicines-related harm. Pharmacy in Practice 2008;18(2):57-61
• Anton C, Cox AR, Ferner RE, Memory loss and confusion with statins: an analysis of spontaneous case reports using the DoTS classification scheme. Drug Safety 2008;31 (10): 911 (Presented at the 8th Annual Meeting of ISoP Buenos Aires - Argentina, 5th-8th October 2008)
• Cox AR, Phull S, Price V, Anton C, Hebron B, Langford NJ, Ferner RE. Retrospective analysis of pharmacy dispensing errors: Twelve years experience in a UK Hospital. Drug Safety; 31 (10): 949 (Presented at the 8th Annual Meeting of ISoP Buenos Aires - Argentina, 5th-8th October 2008)
  
• Cox AR, Wood KMG, Marriott JF, Ferner RE. Causality and definitions: How general practitioners decide what to report to spontaneous reporting schemes. Pharmacoepidemiology and Drug Safety 2008;17(1):S164 (Presented at the 24th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Copenhagen, Denmark, 17-20 August 2008)
• Cox AR, Anton C, Marriott JF, Ferner RE. The paradox of low prescribers who are high reporters: correlates of spontaneous reporting of adverse drug reactions within primary care. Drug Safety 2007; 30(10): 977-978
  (Presented at the 7th Annual Meeting of ISoP Bournemouth - UK, 21-24 October 2007)
• Cox AR, Kirkham H. A Case Study of a Graphical Misrepresentation: Drawing the Wrong Conclusions about the Measles, Mumps and Rubella Virus Vaccine. Drug Safety 2007; 30(10): 831-836
• Cox A, McDowell S. Changing roles, changing risks — the paradox of pharmacist prescribing. The Pharmaceutical Journal. 2007; 278: 46
• Cox AR. Serious ADRs Recognition and management of drug-induced blood disorders. Prescriber 2007; 18 (3) :51-56
• Cox A. Chimeraphobia. The Philosophers’ Magazine 2007; 38: 14-16
• Casiday RE, Cox AR. Restoring confidence in vaccines by explaining vaccine safety monitoring : is a targeted approach needed? Drug Safety 2006; 29(12): 1105-9 [abstract]
• Anton C, Cox AR, Coleman JJ, Ferner RE. A Comparison of Publicly Available Spontaneous Adverse Drug Reaction Data from National Spontaneous Reporting Schemes. Drug Safety 2006; 29(10): 914 (Presented at the 6th Annual Meeting of ISoP Liège - Belgium, 11-13 October 2006) [poster]
• Anton C, Cox AR, Ferner RE. Targetted Follow-Up of Spontaneous ADR Reports to Improve Follow-Up Rates. Drug Safety 2006; 29(10):996 (Presented at the 6th Annual Meeting of ISoP Liège - Belgium, 11-13 October 2006) [presentation]
• Cox AR, Marriott JF, Wood KMG, Ferner RE. General Practitioners’ Attitudes towards Adverse Drug Reaction Reporting: A Qualitative Study. Drug Safety 2006; 29(10):952 (Presented at the 6th Annual Meeting of ISoP Liège - Belgium, 11-13 October 2006) [poster]
• Cox AR, Higham C, Chandler ML, Situnayake RD. Methotrexate: Patient Knowledge of Key Safety Issues. Pharmacoepidemiology and Drug Safety 2006; 15: S288 (Presented at the 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 24-27, 2006 Lisbon, Portugal) [poster]
• Cox AR. Prevention and management of drug-induced ocular disorders. Prescriber 2006:17(12): 39-42 [PDF]

Book chapters

• Layton D, Cox A. Pharmacovigilance. In: Bond C editor. Using Medicines Information. Oxford, Radcliffe Publishing 2007. p. 141-168.

• Ferner RE, Langford NJ, Cox AR. Testamentary capacity. In Payne-James J, Byard R, Corey T, Henderson C. editors. Encyclopedia of Forensic and Legal Medicine. New York: Academic Press; 2005. p252-258. [Link]

• Langford NJ, Cox A. Interactions between Antihypertensive Drugs and Other Medications. In: Comprehensive Hypertension. Editors: Lip GHY, Hall JE. Philadelphia, Mosby Elsevier; 2007. 1075-1086.

Other publications

• Cox AR. (2005) Yellow Card Reporting Scheme: What to report and where to? Tomorrow’s Pharmacist. 66-67.
• Cox AR, Langford N. BANs to rINNS. (2004) Journal of Clinical Pharmacy and Therapeutics. 29:491-495 [PDF]
• Cox AR, Marriott JF, Wilson KA, Ferner RE. (2004) Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes. Journal of Clinical Pharmacy and Therapeutics. 29 , 31-35.[Abstract]
• Cox AR, Langford N. (2003) Drug-induced cardiac failure. Adverse Drug Reaction Bulletin. 220 , 843-846.
• Anton C, Cox AR, Watson RDS, Ferner RE. (2003) The safety of spironolactone treatment in patients with heart failure. Journal of Clinical Pharmacy & Therapeutics. 28(4) , 285-287. [Abstract]
• Kerr KL, Higham C, Cox AR, Situnayake RD. (2003) A determination of patient awareness of the safety issues surrounding treatment with methotrexate. The Pharmaceutical Journal. 271 , 900-901. [Full Paper PDF]
• Whitaker, S., Cox, A.R., and Alexander, A.M. (2003) Internet networking for pharmacists: an evaluation of a mailing list for UK registered pharmacists International Journal of Pharmacy Practice. 11 , 25-32 [Abstract]
• Cox, A.R. (2002) Systemic effects of ocular drugs Adverse Drug Reaction Bulletin . 215 , 823-826
• Cox, A., and Jenkins, A. (2002) A case of carboplatin hypersensivity. Pharmacy in Practice. 12(5), 187
• Cox, A, and Millane, T. (2002) An adverse drug reaction as a consequence of error. Pharmacy in Practice. 12(2), 84-86
• Cox, A., Anton, C., Goh, C.H.F., Easter, M., Langford, N.J., and Ferner, R.E. (2001) Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports. British Journal of Clinical Pharmacology. 52 , 337-339 [Abstract]
• Jenkins, A., and Cox, A. (2002) Influenza vaccine and warfarin. Pharmacy in Practice. 12(1) ,42
• Cox, A. (2001) Syncope as a possible adverse drug reaction. Pharmacy in Practice. 11(9) , 286
• Bradley, M.J., and Cox, A. (2001) Suspected interaction betweeen celecoxib and warfarin. Pharmacy in Practice. 11(8) :243-245
• Cox, A.R. (2001) Hypokalaemia associated with the use of spironolactone in heart failure. Pharmacy in Practice . 11(6), 187-189
• Cox, A.R., and Barnett, A.L.(2001) Reporting reactions to newly marketed drugs. Pharmacy in Practice . 11(4) ,121-122
• Cox, A.R. (2001) What can hospital pharmacy do to increase adverse drug reaction reporting. Pharmacy in Practice. 11(3) , 84
• Cox, A.R. (2001) Haematoma associated with tirofiban and enoxaparin in an unstable angina patient. Pharmacy in Practice. 11(3) , 87-88
• Cox, A.R. (2001) Adverse reactions to intra-vascular radiological contrast media. Pharmacy in Practice. 11(2), 54-55
• Cox, A.R. (2000) The pharmacist's role in adverse drug reactions. Pharmacy in Practice . 10(7), 262-3
• Cox, A.R. (2000) The Committee on Safety of Medicine's Yellow Card Scheme. Pharmacy in Practice . 10(6) , 213-15

Book reviews

• Cox AR. New Edition affirms place as key text in the area of pharmacovigilance. The Pharmaceutical Journal. 2004;272:393 [Text] (Review of ‘Stephens’ detection of new adverse drug reactions’, 5th edition)
• Cox A, Book Review - Martindale 33rd edition.The Pharmaceutical Journal 2002; 268:505.[text]

Government work

• Report to the Committee on Safety of Medicines from the Working Group on Labelling and Packaging of Medicines MLX 275 (2001) Medicines Control Agency, London.

Letters

• Cox A, Langford N. Partisan editorials serve no one, least of all new prescribers. The Pharmaceutical Journal 2006; 276: 621 [text]
• Cox AR. (2004) Colchicine in acute gout: Optimal dose of colchicine is still elusive. BMJ 328: 288. [text]
• Cox AR. (2003) Manufacturers should make reading labels easier. The Pharmaceutical Journal. 270 , 514. [text]
• Cox AR, Anton C.(2003) Report [...] drug reactions with warfarin. The Pharmaceutical Journal. 270 ,366-367 [text]
• Cox, A.R(2002) Prescribers need appraisal training programmes. The Pharmaceutical Journal. 270 , 154
• Anton, C., Cox, A.R., and Ferner, R.E. (2002) Using trade names: sometimes it helps. Archives of Internal Medicine 162 , 2636-2637
• Anton, C., and Cox, A. (2001) Adverse Drug reactions. British Journal of General Practice 51 (468), 582-683
• Cox, A., and Anton, C. (2001) Safety profile of bupropion for chronic obstructive pulmonary disease. The Lancet 358 ,1010
• Cox, A., Anton, C., and Ferner, R. (2001) Take care with Zyban. The Pharmaceutical Journal 266 , 718-722

Abstracts

• Cox AR, Marriott JF, Wilson KA, Ferner RE. (2004) Message from the top: chief pharmacists’ views of adverse drug reaction reporting. International Journal of Pharmacy Practice. 12(suppl):R68
• Cox, A.R., Marriott, J.F., Wilson, K.W., and Ferner, R.E. Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes.The 18th International Conference on Pharmacoepidemiology , Edinburgh. 2002.
• Dent, S.N., Cox, A.R., Marriott, J.F., Langley, C.A., and Wilson, K.A. (2002) Warfarin toxicity: do discharge ICD-codes and yellow cards accurately identify serious adverse drug reactions? The International Journal of Pharmacy Practice . 10(suppl), R40
• Rippengill, K.L., Higham, C., Cox, A.R., and Situnayake, R.D. (2002) Methotrexate - patient awareness and safety issues Pharmacy World & Science . 24(3), A21
• Mundia, A.N., Cox, A.R., and Marriott, J.F. (2001) Discordance: coronary care patient's knowledge of Medicines. GHP. 2(2) ,14
• Whitaker, S., Cox, A.R., and Alexander, A.M. (2000) The members, the medium and the message: an evaluation of Private-Rx, the information network for UK pharmacists. The Pharmaceutical Journal. 265, R73

Editorials

• Cox AR. Lessons from TGN1412. Prescriber 2006;17:9 [PDF]
• Cox AR. (2003) Let us be called the Royal Society of Pharmacists of Great Britain. The Pharmaceutical Journal. 2003; 271 , 44. [text] [PDF]
• Cox, A.R. (2002) Embracing ADR reporting could improve pharmacists' standing. The Pharmaceutical Journal. 269 , 14
• Cox, A.R., and Marriott, J.F. (2002) Take a spoonful of sugar with salt. The Hospital Pharmacist. 9(4) , 90
• Cox, A.R., and Marriott, J. (2001) Is self-checking (by anyone) a risk too far? The Pharmaceutical Journal. 266, 814
• Cox, A.R., and Marriott, J.F. (2000) Dealing with dispensing errors. The Pharmaceutical Journal. 264 , 724

Magazine articles

• Cox AR. (19th July 2003) The war on the web: Googlebomb of mass destruction. The Guardian. [text]
• Cox, A.R ( January 2003) IT update: Net Result. Independent Community Pharmacist , 18
• Cox, A.R., and Marriott, J.F. (Feb 2002) Safety First. Pharmaceutical Marketing [Text]

Other contributions

• Contributor to A Risky Business – Minimising Medication Errors. CPPE workshop 2001. [link]

Anthony Cox / Aston University / last updated December 2006